Abstract
This chapter focuses on nodular B-lymphocyte reactive hyperplasia (pseudolymphoma) including classification, historical overview and clarification of nomenclature, epidemiology, clinical and histomorphological features, cytogenetics and molecular features, and clinical course. At the outset, we give an overview of normal B-lymphocyte ontogeny. Entities specifically discussed in-depth include idiopathic lymphocytoma cutis, lymphomatoid drug-induced pseudo B-cell lymphoma, and cutaneous lymphoid hyperplasia secondary to foreign bodies – reaction to tattoo, pseudo B-cell lymphoma secondary to infections, pseudolymphoma at sites of vaccination, persistent nodular arthropod-bite reactions, and nodular scabies. We conclude by discussing mimickers, the significance of clonality and clues to diagnosis. There is no single histopathologic criterion to cutaneous B-cell pseudolymphomas (CBPL) from cutaneous B-cell lymphomas (CBCL). Histologic diagnosis of CBPL depends on two considerations: (1) the architecture of the infiltrate and (2) the composition and cytomorphology of cells in the infiltrate. Histopathologic features that favor CBPL over CBCL include (1) acanthosis, (2) a top-heavy infiltrate, (3) a mixed (T- and B-lymphocyte-rich) infiltrate, (4) absence of mitosis outside of the germinal center and/or necrosis, (5) regular appearing germinal centers, (6) presence of tingible bodies in the germinal centers, (7) lack of cohesion of lymphoid cells, (8) infiltrative border (concave), (9) preservation of adnexal structures with the infiltrate respecting adnexal epithelium, and (10) stromal fibrosis. A useful immunohistochemical feature for distinguishing cutaneous follicle-center cell lymphoma from cutaneous lymphoid hyperplasia is the presence of small clusters of CD10+/Bcl6+ lymphocytes in the interfollicular zones and positive Bcl2 staining in the follicles in the former. Furthermore, there is a low MIB-1 proliferation fraction in lymphoma compared with cutaneous lymphoid hyperplasia.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abbas A, Lightman A, Pober J. Maturation of B lymphocytes and expression of immunoglobulin. Philadelphia: W. B. Saunders Company; 1991. 71 p. (Cellular and molecular immunology).
Abell E, Marks R, Jones EW. Secondary syphilis: a clinico-pathological review. Br J Dermatol. 1975;93(1):53–61.
Ackerman A. Histologic diagnosis of inflammatory skin diseases. Philadelphia: Lea & Febiger; 1978. p. 442–7.
Ackerman A, Briggs P, Bravo F. Differential diagnosis in dermatopathology III. Philadelphia: Lea & Febiger; 1993. p. 46–9.
Aguilar J, Barcelo C, Martin-Urda M, et al. Generalized cutaneous B-cell pseudolymphoma induced by neuroleptics. Arch Dermatol Res. 1992;128:121–3.
Aigelsreiter A, Pump A, Buchhausl W, et al. Successful antibiotic treatment of Borreliosis associated pseudolymphomatous systemic infiltrates. J Infect. 2005;51(4):e203–6.
Albrecht S, Hofstadter S, Artsob H, et al. Lymphadenosis benigna cutis resulting from Borrelia infection (Borrelia lymphocytoma). J Am Acad Dermatol. 1991;24(4):621–5.
Amichai B, Grunwald MH, Avinoach I, et al. Granulomatous rosacea associated with Demodex folliculorum. Int J Dermatol. 1992;31(10):718–9.
Asbrink E, Hovmark A. Lyme borreliosis. In: Fitzpatrick T, Eisen A, Wolff K, et al., editors. Dermatology in general medicine. 4th ed. New York: McGraw-Hill; 1993. p. 2410–20.
Battistella M, Le Cleach L, Lacert A, et al. Extensive nodular secondary syphilis with prozone phenomenon. Arch Dermatol. 2008;144(8):1078–9.
Behan PO, Behan WM, Zacharias FJ, et al. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet. 1976;2(7993):984–7.
Bergman R, Khamaysi Z, Sahar D, et al. Cutaneous lymphoid hyperplasia presenting as a solitary facial nodule: clinical, histopathological, immunophenotypical, and molecular studies. Arch Dermatol. 2006;142(12):1561–6.
Bergman R, Khamaysi K, Khamaysi Z, et al. A study of histologic and immunophenotypical staining patterns in cutaneous lymphoid hyperplasia. J Am Acad Dermatol. 2011;65(1):112–24.
Berti E, Alessi E, Caputo R. Reticulohistiocytoma of the dorsum (Crosti’s disease) and other B-cell lymphomas. Semin Diagn Pathol. 1991;8(2):82–90.
Bluefarb S. Lymphocytoma cutis. In: Bluefarb S, editor. Cutaneous manifestations of the benign inflammatory reticuloses. Springfield: Charles C Thomas; 1960. p. 131–99.
Blumental G, Okun MR, Ponitch JA. Pseudolymphomatous reaction to tattoos. Report of three cases. J Am Acad Dermatol. 1982;6(4 Pt 1):485–8.
Bluming A, Homer S, Khiroya R. Selective diphenylhydantoin-induced suppression of lymphocyte reactivity in vitro. J Lab Clin Med. 1976;88(3):417–22.
Boer A, Tirumalae R, Bresch M, et al. Pseudoclonality in cutaneous pseudolymphomas: a pitfall in interpretation of rearrangement studies. Br J Dermatol. 2008;159(2):394–402.
Boudova L, Kazakov DV, Sima R, et al. Cutaneous lymphoid hyperplasia and other lymphoid infiltrates of the breast nipple: a retrospective clinicopathologic study of fifty-six patients. Am J Dermatopathol. 2005;27(5):375–86.
Brandes LJ, Arron RJ, Bogdanovic RP, et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res. 1992;52(13):3796–800.
Bratzke B, Stadler R, Gollnick H, et al. Borrelia burgdorferi-induced pseudolymphoma with pathogen cultivation in an HIV-1 positive patient. Hautarzt. 1989;40(8):504–9.
Breza Jr TS, Zheng P, Porcu P, et al. Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response. J Cutan Pathol. 2006;33(7):522–8.
Brodell RT, Santa Cruz DJ. Cutaneous pseudolymphomas. Dermatol Clin. 1985;3(4):719–34.
Brown TJ, Yen-Moore A, Tyring SK. An overview of sexually transmitted diseases. Part I. J Am Acad Dermatol. 1999;41(4):511–32.
Bucher S, Fluckiger B, Rufli T. Infiltrating lymphadenosis benigna cutis as borreliosis of the skin. Hautarzt. 1988;39:77–81.
Burg G, Schmid MH, Kung E, et al. Semimalignant (“pseudolymphomatous”) cutaneous B-cell lymphomas. Dermatol Clin. 1994;12(2):399–407.
Carlson JA, Ackerman AB, Fletcher CD, et al. A cutaneous spindle-cell lesion. Am J Dermatopathol. 2001;23(1):62–6.
Caro WA, Helwig HB. Cutaneous lymphoid hyperplasia. Cancer. 1969;24(3):487–502.
Ceballos KM, Gascoyne RD, Martinka M, et al. Heavy multinodular cutaneous lymphoid infiltrates: clinicopathologic features and B-cell clonality. J Cutan Pathol. 2002;29(3):159–67.
Cerio R, Oliver GF, Jones EW, et al. The heterogeneity of Jessner’s lymphocytic infiltration of the skin. Immunohistochemical studies suggesting one form of perivascular lymphocytoma. J Am Acad Dermatol. 1990;23(1):63–7.
Cerroni L, Kerl H. The use of monoclonal antibodies on paraffin sections in the diagnosis of cutaneous lymphoproliferative disorders. Dermatol Clin. 1994;12(2):219–29.
Cerroni L, Borroni RG, Massone C, et al. Cutaneous B-cell pseudolymphoma at the site of vaccination. Am J Dermatopathol. 2007;29(6):538–42.
Chayavichitsilp P, Buckwalter JV, Krakowski AC, et al. Herpes simplex. Pediatr Rev. 2009;30(4):119–29. quiz 30.
Chimenti S, Cerroni L, Zenahlik P, et al. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation. J Cutan Pathol. 1996;23(4):319–22.
Choi TS, Doh KS, Kim SH, et al. Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome. Br J Dermatol. 2003;148(4):730–6.
Chong H, Brady K, Metze D, et al. Persistent nodules at injection sites (aluminium granuloma) – clinicopathological study of 14 cases with a diverse range of histological reaction patterns. Histopathology. 2006;48(2):182–8.
Clark WH, Mihm Jr MC, Reed RJ, et al. The lymphocytic infiltrates of the skin. Hum Pathol. 1974;5(1):25–43.
Cochran RE, Thomson J, Fleming KA, et al. Histology simulating reticulosis in secondary syphilis. Br J Dermatol. 1976;95(3):251–4.
Coffin CM, Humphrey PA, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol. 1998;15(2):85–101.
Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31(4):509–20.
Colli C, Leinweber B, Mullegger R, et al. Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol. 2004;31(3):232–40.
Connors RC, Ackerman AB. Histologic pseudomalignancies of the skin. Arch Dermatol. 1976;112(12):1767–80.
Crowson AN, Magro CM. Antidepressant therapy. A possible cause of atypical cutaneous lymphoid hyperplasia. Arch Dermatol. 1995;131(8):925–9.
Cruz FA, Lage D, Frigerio RM, et al. Reactions to the different pigments in tattoos: a report of two cases. An Bras Dermatol. 2010;85(5):708–11.
Damle NK, Gupta S. Autologous mixed lymphocyte reaction in man. III. Regulation of autologous MLR by theophylline-resistant and -sensitive human T-lymphocyte subpopulations. Scand J Immunol. 1981;15(5):493–9.
Dorfman RF, Warnke R. Lymphadenopathy simulating the malignant lymphomas. Hum Pathol. 1974;5(5):519–50.
Dosch HM, Jason J, Gelfand EW. Transient antibody deficiency and abnormal t-suppressor cells induced by phenytoin. N Engl J Med. 1982;306(7):406–9.
Duncan SC, Evans HL, Winkelmann RK. Large cell lymphocytoma. Arch Dermatol. 1980;116(10):1142–6.
El Shabrawi-Caelen L, Kerl K, Cerroni L, et al. Cutaneous inflammatory pseudotumor – a spectrum of various diseases? J Cutan Pathol. 2004;31(9):605–11.
English J, Smith N, Jones WE. Large cell lymphocytoma. J Cutan Pathol. 1986;13:441.
English J, Smith NP, Spaull J, et al. Large cell lymphocytoma – a clinicopathological study. Clin Exp Dermatol. 1989;14(3):181–5.
Erfurt C, Lueftl M, Simon Jr M, et al. Late syphilis mimicking a pseudolymphoma of the skin. Eur J Dermatol. 2006;16(4):431–4.
Evans HL, Winkelmann RK, Banks PM. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: a study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin. Cancer. 1979;44(2):699–717.
Facchetti F, Boden G, De Wolf-Peeters C, et al. Plasmacytoid monocytes in Jessner’s lymphocytic infiltration of the skin. Am J Dermatopathol. 1990;12(4):363–9.
Falk ES, Eide TJ. Histologic and clinical findings in human scabies. Int J Dermatol. 1981;20(9):600–5.
Fernandez N, Torres A, Ackerman AB. Pathologic findings in human scabies. Arch Dermatol. 1977;113(3):320–4.
Friedmann K. Nodular or diffuse infiltrates. In: Farmer E, Hood A, editors. Pathology of the skin. Norwalk: Appleton & Lange; 1990. p. 207–11.
Friedmann D, Wechsler J, Delfau MH, et al. Primary cutaneous pleomorphic small T-cell lymphoma. A review of 11 cases. The French Study Group on Cutaneous Lymphomas. Arch Dermatol. 1995;131(9):1009–15.
Gartman H. Generalisierte pseudolymphoma der haut. Hautarzt. 1986;55:166.
Giannotti B, Santucci M. Skin-associated lymphoid tissue (SALT)-related B-cell lymphoma (primary cutaneous B-cell lymphoma). A concept and a clinicopathologic entity. Arch Dermatol. 1993;129(3):353–5.
Goffinet DR, Hoyt C, Eltringham JR. Secondary syphilis misdiagnosed as a lymphoma. Calif Med. 1970;112(5):22–3.
Gollnick H, Mayer-da-Silva A, Thies W, et al. Infection with Treponema pallidum and HTLV-1 mimicking cutaneous T-cell lym- phoma. In: Mascaro JM, Orfanos CE editors. Clinical dermatology: the CMD case collection. New York: Schattauer, Stuttgart; 1987. p. 108–10.
Grange F, Wechsler J, Guillaume JC, et al. Borrelia burgdorferi-associated lymphocytoma cutis simulating a primary cutaneous large B-cell lymphoma. J Am Acad Dermatol. 2002;47(4):530–4.
Halevy S, Sandbank M. Transformation of lymphocytoma cutis into a malignant lymphoma in association with the sign of Leser-Trelat. Acta Derm Venereol. 1987;67(2):172–5.
Helm KF, Muller SA. Benign lymphocytic infiltrate of the skin: correlation of clinical and pathologic findings. Mayo Clin Proc. 1992;67(8):748–54.
Helm KF, Menz J, Gibson LE, et al. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol. 1991;25(6 Pt 1):1038–43.
Hicks MI, Elston DM. Scabies. Dermatol Ther. 2009;22(4):279–92.
Hodak E, David M, Rothem A, et al. Nodular secondary syphilis mimicking cutaneous lymphoreticular process. J Am Acad Dermatol. 1987;17(5 Pt 2):914–7.
Hovmark A, Asbrink E, Olsson I. The spirochetal etiology of lymphadenosis benigna cutis solitaria. Acta Derm Venereol. 1986;66(6):479–84.
Hurt MA, Santa Cruz DJ. Cutaneous inflammatory pseudotumor. Lesions resembling “inflammatory pseudotumors” or “plasma cell granulomas” of extracutaneous sites. Am J Surg Pathol. 1990;14(8):764–73.
Imafuku S, Ito K, Nakayama J. Cutaneous pseudolymphoma induced by adalimumab and reproduced by infliximab in a patient with arthropathic psoriasis. Br J Dermatol. 2012;166(3):675–8.
Jeerapaet P, Ackerman A. Histologic patterns of secondary syphilis. Arch Dermatol Res. 1974;107:373–7.
Jessner M, Kanof N. Lymphocytic infiltration of the skin. Arch Dermatol. 1953;68:447–9.
Kahofer P, El Shabrawi-Caelen L, Horn M, et al. Pseudolymphoma occurring in a tattoo. Eur J Dermatol. 2003;13(2):209–12.
Kardaun SH, Scheffer E, Vermeer BJ. Drug-induced pseudolymphomatous skin reactions. Br J Dermatol. 1988;118(4):545–52.
Kazandjieva J, Tsankov N. Tattoos: dermatological complications. Clin Dermatol. 2007;25(4):375–82.
Kerl H. Cutaneous pseudolymphomas. In: Eisen A; K Wolff K et al. editors. Proceedings of the XVI international congress of dermatology. Tokyo: University of Tokyo Press; 1983. p. 189–95.
Kerl H, Ackerman AB. Inflammatory diseases that simulate lymphomas: cutaneous pseudolymphomas. Dermatology in general medicine. 4th ed. New York: McGraw-Hill; 1993. p. 1315–27.
Konttinen YT, Bergroth V, Johansson E, et al. A long-term clinicopathologic survey of patients with Jessner’s lymphocytic infiltration of the skin. J Invest Dermatol. 1987;89(2):205–8.
Kuo TT, Lo SK, Chan HL. Immunohistochemical analysis of dermal mononuclear cell infiltrates in cutaneous lupus erythematosus, polymorphous light eruption, lymphocytic infiltration of Jessner, and cutaneous lymphoid hyperplasia: a comparative differential study. J Cutan Pathol. 1994;21(5):430–6.
LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood. 2008;112(5):1570–80.
LeBoit PE, McNutt NS, Reed JA, et al. Primary cutaneous immunocytoma. A B-cell lymphoma that can easily be mistaken for cutaneous lymphoid hyperplasia. Am J Surg Pathol. 1994;18(10):969–78.
Leinweber B, Colli C, Chott A, et al. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern. Am J Dermatopathol. 2004;26(1):4–13.
Lever W, Schaumburg-Lever G. Lymphocytoma. Odland GF translator. In: Goldsmith LA, editor. Histopathology of the skin. 7 ed. Philadelphia: JB Lippincott; 1990. p. 837–46.
Lubach D, Hinz E. A pseudolymphomatous reaction in tattooing. Hautarzt. 1986;37(10):573–5.
MacKie R. Cutaneous lymphocytic infiltrates and pseudolymphomas. In: Champion R, Burton J, Ebling F, editors. Textbook of dermatology. 5th ed. London: Blackwell Scientific Publications; 1993. p. 2101–5.
MacSweeney F, Desai SA. Inflammatory pseudotumour of the subcutis: a report on the fine needle aspiration findings in a case misdiagnosed cytologically as malignant. Cytopathology. 2000;11(1):57–60.
Magro CM, Crowson AN. Drugs with antihistaminic properties as a cause of atypical cutaneous lymphoid hyperplasia. J Am Acad Dermatol. 1995;32(3):419–28.
McComb ME, Telang GH, Vonderheid EC. Secondary syphilis presenting as pseudolymphoma of the skin. J Am Acad Dermatol. 2003;49(2 Suppl Case Reports):S174–6.
McMillen MA, Lewis T, Jaffe BM, et al. Verapamil inhibition of lymphocyte proliferation and function in vitro. J Surg Res. 1985;39(1):76–80.
Moon HS, Park K, Lee JH, et al. A nodular syphilid presenting as a pseudolymphoma: mimicking a cutaneous marginal zone B-cell lymphoma. Am J Dermatopathol. 2009;31(8):846–8.
Moreno A, Curco N, Serrano T, et al. Disseminated, miliarial type lymphocytoma cutis. A report of two cases. Acta Derm Venereol. 1991;71(4):334–6.
Nathan DL, Belsito DV. Carbamazepine-induced pseudolymphoma with CD-30 positive cells. J Am Acad Dermatol. 1998;38(5 Pt 2):806–9.
Nihal M, Mikkola D, Horvath N, et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol. 2003;34(6):617–22.
Paley K, Geskin LJ, Zirwas MJ. Cutaneous B-cell pseudolymphoma due to paraphenylenediamine. Am J Dermatopathol. 2006;28(5):438–41.
Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol. 1998;38(6 Pt 1):877–95. quiz 96-7.
Ramachandra S, Hollowood K, Bisceglia M, et al. Inflammatory pseudotumour of soft tissues: a clinicopathological and immunohistochemical analysis of 18 cases. Histopathology. 1995;27(4):313–23.
Rashidi A, Dorfler KR, Goodman BM. Diffuse Kaposi’s sarcoma. Int J Dermatol. 2012;51(8):964–5.
Remy-Leroux V, Leonard F, Lambert D, et al. Comparison of histopathologic-clinical characteristics of Jessner’s lymphocytic infiltration of the skin and lupus erythematosus tumidus: multicenter study of 46 cases. J Am Acad Dermatol. 2008;58(2):217–23.
Rijlaarsdam JU, Bruynzeel DP, Vos W, et al. Immunohistochemical studies of lymphadenosis benigna cutis occurring in a tattoo. Am J Dermatopathol. 1988;10(6):518–23.
Rijlaarsdam JU, Willemze R. Cutaneous pseudolymphomas: classification and differential diagnosis. Semin Dermatol. 1994;13(3):187–96.
Rijlaarsdam J, Meijer C, Willemze R. Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphomas. Cancer Res. 1990;65:2301–6.
Rijlaarsdam JU, van der Putte SC, Berti E, et al. Cutaneous immunocytomas: a clinicopathologic study of 26 cases. Histopathology. 1993;23(2):117–25.
Sanches M. Syphilis. In: Freedberg I, Eisen A, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. 6th ed. New York: McGraw Hill; 2003. p. 2163–88. Vol. 2.
Sanchez-Viera M, Hernanz JM, Sampelayo T, et al. Granulomatous rosacea in a child infected with the human immunodeficiency virus. J Am Acad Dermatol. 1992;27(6 Pt 1):1010–1.
Sangueza OP, Yadav S, White Jr CR, et al. Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis. Am J Dermatopathol. 1992;14(5):408–13.
Santucci M, Pimpinelli N, Arganini L. Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases. Cancer. 1991;67(9):2311–26.
Sawada Y, Yoshiki R, Kawakami C, et al. Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption. Acta Derm Venereol. 2010;90(5):521–2.
Schmutz JL, Trechot P. Cutaneous pseudolymphoma with two types of anti-TNFalpha: a class effect? Ann Dermatol Venereol. 2012;139(10):695–6.
Schreiber MM, McGregor JG. Pseudolymphoma syndrome. A sensitivity to anticonvulsant drugs. Arch Dermatol. 1968;97(3):297–300.
Self SJ, Carter VH, Noojin RO. Disseminated lymphocytoma cutis. Case reports of miliarial and nodular types. Arch Dermatol. 1969;100(4):459–64.
Shiino S, Kojima M, Arisawa T, et al. Presence of immunoglobulin heavy chain rearrangement in so-called IgG4-related plasma cell granuloma of the eyelid. J Clin Exp Hematop. 2012;52(2):141–3.
Sowden JM, Cartwright PH, Smith AG, et al. Sarcoidosis presenting with a granulomatous reaction confined to red tattoos. Clin Exp Dermatol. 1992;17(6):446–8.
Spray A, Glaser DA. Herpes zoster of the penis: an unusual location for a common eruption. J Am Acad Dermatol. 2002;47(2 Suppl):S177–9.
Stanek G, Wewalka G, Groh V, et al. Differences between Lyme disease and European arthropod-borne Borrelia infections. Lancet. 1985;1(8425):401.
Stirn A, Brahler E, Hinz A. Prevalence, sociodemography, mental health and gender differences of tattooing and body piercing. Psychother Psychosom Med Psychol. 2006;56(11):445–9.
Toonstra J, Wildschut A, Boer J, et al. Jessner's lymphocytic infiltration of the skin. A clinical study of 100 patients. Arch Dermatol. 1989;125(11):1525–30.
Torne R, Roura M, Umbert P. Generalized cutaneous B-cell pseudolymphoma. Report of a case studied by immunohistochemistry. Am J Dermatopathol. 1989;11(6):544–8.
Triscott JA, Ritter JH, Swanson PE, et al. Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasias. J Cutan Pathol. 1995;22(1):2–10.
ul Bari A, Raza N. Secondary syphilis clinically mimicking pseudolymphoma of the face. Dermatol Online J. 2006;12(3):20.
van der Putte SC, Toonstra J, Schuurman HJ, et al. Immunocytoma of the skin simulating lymphadenosis benigna cutis. Arch Dermatol Res. 1985;277(1):36–43.
Van Hale HM, Winkelmann RK. Nodular lymphoid disease of the head and neck: lymphocytoma cutis, benign lymphocytic infiltrate of Jessner, and their distinction from malignant lymphoma. J Am Acad Dermatol. 1985;12(3):455–61.
Walton SF, Currie BJ. Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev. 2007;20(2):268–79.
Wantzin GL, Hou-Jensen K, Nielsen M, et al. Cutaneous lymphocytomas: clinical and histological aspects. Acta Derm Venereol. 1982;62(2):119–24.
Wantzin GL, Thomsen K, Ralfkiaer E. Evolution of cutaneous lymphoid hyperplasia to cutaneous T-cell lymphoma. Clin Exp Dermatol. 1988;13(5):309–13.
Weber K, Schierz G, Wilske B, et al. European erythema migrans disease and related disorders. Yale J Biol Med. 1984;57(4):463–71.
Wechsler J, Bagot M, Henni T, et al. Cutaneous pseudolymphomas: immunophenotypical and immunogenotypical studies. Curr Probl Dermatol. 1990;19:183–8.
Weinberg JM, Rook AH, Lessin SR. Molecular diagnosis of lymphocytic infiltrates of the skin. Arch Dermatol. 1993;129(11):1491–500.
Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46(4):584–7.
Willemze R, Dijkstra A, Meijer CJ. Lymphocytic infiltration of the skin (Jessner): a T-cell lymphoproliferative disease. Br J Dermatol. 1984;110(5):523–9.
Winkelmann RK, Dabski K. Large cell lymphocytoma: follow-up, immunopathology studies, and comparison to cutaneous follicular and Crosti lymphoma. Arch Dermatol Res. 1987;279(Suppl):S81–7.
Xu F, Sternberg MR, Gottlieb SL, et al. Seroprevalence of herpes simplex virus type 2 among persons aged 14–49 years – United States, 2005–2008. Centers for Disease Control and Prevention (CDC). 2010;59(15):456–9.
Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964–73.
Yang M. Cutaneous inflammatory pseudotumor: a case report with immunohistochemical and ultrastructural studies. Pathology. 1993;25(4):405–9.
Zackheim HS, LeBoit PE, Stein KM. Disseminated recurrent papular B-cell pseudolymphoma. Int J Dermatol. 1997;36(8):614–8.
Acknowledgments
The authors would like to acknowledge Amy C Mueller, BA for assistance with formatting and cataloguing of references.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Aung, P.P., Mahalingam, M. (2014). Nodular B-Lymphocyte Reactive Patterns: Reactive Nodular B-Cell Pattern. In: Cualing, H., Kadin, M., Hoang, M., Morgan, M. (eds) Cutaneous Hematopathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0950-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0950-6_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0949-0
Online ISBN: 978-1-4939-0950-6
eBook Packages: MedicineMedicine (R0)